当前位置:主页 > 医学论文 > 西医药论文 >

重组水蛭素对大鼠撕脱皮瓣存活影响的实验研究

发布时间:2018-05-25 00:01

  本文选题:重组水蛭素 + 撕脱皮瓣 ; 参考:《泸州医学院》2012年硕士论文


【摘要】:目的:本实验通过建立大鼠背部撕脱皮瓣模型,研究重组水蛭素对撕脱皮瓣的保护作用及其机制,并探讨重组水蛭素在临床治疗撕脱皮瓣的应用前景。方法:选用健康SD大鼠108只,雌雄不拘,体重(250±50g),随机分为3组:2个治疗组(A组:重组水蛭素治疗组,B组:低分子肝素治疗组)和1个空白对照组(C组:注射用生理盐水组),每组36只,按40mg/kg体重、1%戊巴比妥钠腹腔注射麻醉,以背部中线为准,蒂位于头侧,设计4cm×6cm大小的长方形随意皮瓣,蒂部行保护性固定后,远端用缝线固定于细铁棒后与精密称量的重物相连,施予均为8kg的牵拉力,时间均为10秒形成撕脱皮瓣模型,远端游离缘稍加修剪后原位缝合。分别于术后即刻、12小时、24小时、48小时于皮瓣蒂部、距蒂部2cm和4cm三等分点皮下均匀注射重组水蛭素(2mg/lml/皮瓣)、低分子肝素(2mg/lml/皮瓣),空白对照组同法给予注射等量生理盐水(1m1/皮瓣)。术后观察皮瓣表面毛发生长情况,淤血、肿胀情况,皮瓣存活面积;分别检测术后12h、1d、3d皮瓣远端组织内P-选择素含量,3d、5d、7d皮瓣远端组织内VEGF含量;高倍镜下观察术后12h、1d、3d、5d、7d皮瓣远端组织病理切片内毛细血管内炎性细胞聚集情况及微血栓形成情况。 结果:1.大体观察:术后12、24小时3组皮瓣均出现不同程度的发绀、肿胀,空白对照组较两治疗组发绀、肿胀严重;空白对照组淤滞带界限较清晰,治疗组淤滞带界限不清。术后第5、7天,治疗组皮瓣远端发绀、肿胀逐步消退,存活良好。空白对照组皮瓣远端和周缘仍较肿胀,且呈暗黑色,质地变硬,表面毛发有脱失,未见毛细血管反应,趋向于坏死。术后第14天重组水蛭素组和低分子肝素组存活面积百分比分别为(86.07±1.30)%和(81.46±1.06)%,均比空白对照组(77.03±1.25)%高,有显著性差异(p0.01),重组水蛭素组比低分子肝素组皮瓣成活率高,差异有统计学意义(p0.05)2.组织学观察:术后12h:空白对照组镜下见组织内大片出血区,充血、水肿明显,有大量中性粒细胞浸润;肝素组镜下见组织内片状出血、充血,水肿较明显,有较多中性粒细胞浸润;重组水蛭素组镜下见组织内点状出血,可见充血,水肿,少量中性粒细胞浸润。1d:空白对照组镜下见组织内大片出血区,充血、水肿明显,中性粒细胞呈团块状聚集,并可见早期坏死;肝素组镜下见组织内充血、水肿,中性粒细胞浸润等均较明显;重组水蛭素组镜下见组织内充血、水肿,可见数量不等的中性粒细胞散在存在。3d:空白对照组镜下见组织内大片出血,淤血明显,大量形成炎性肉芽组织,其中可见中性粒细胞散在存在;肝素组镜下见组织内淤血、水肿,有炎性肉芽组织形成,可见中性粒细胞散在分布;重组水蛭素组镜下见组织内散在淤血,出血少见,炎性肉芽组织形成,散在的少量中性粒细胞。5d:空白对照组镜下可见少量片状出血、淤血,可见微血栓形成,炎性肉芽组织水肿;肝素组镜下见少量淤血、水肿,炎性肉芽组织较成熟;重组水蛭素组镜下见少量淤血,炎性肉芽组织成熟。7d:空白对照组镜下见组织内微血栓形成,毛细血管闭塞,新生毛细血管少;肝素组镜下见组织内少量微血栓形成,有新生毛细血管;重组水蛭素组镜下见组织内新生血管增生活跃,肉芽组织成熟。3.P-选择素含量检测(pg/m1):术后第12小时、1天、3大,重组水蛭素组与低分子肝素组P-选择素含量分别为(129.740±12.302)与(151.584±12.409)(111.030±6.824)与(134.434±8.707)、(101.674±4.429)与(118.308±7.535),其对应空白组为(196.034±18.442)(162.087±14.485)、(132.473±8.142),第12小时、1天、3天重组水蛭素组与低分子肝素组和空白对照组之间差异有统计学意义(P0.05)。4.VEGF含量检测:术后第3、5、7天,重组水蛭素组与低分子肝素组VEGF含量分别为(212.507±15.096)与(158.733±15.311)、(214.010±13.811)与(167.134±11.455)、(218.093±13.464)与(177.484±8.183),其对应空白组为(120.454±7.575)、(130.133±19.159)、(133.800±4.882),第3、5、7天重组水蛭素组与低分子肝素组和空白对照组之间差异有统计学意义(P0.05)。结论:局部注射重组水蛭素能有效抑制P-选择素的生成,减少炎性细胞的聚集,阻断微血栓的形成,改善撕脱皮瓣局部缺血、缺氧状态;减弱内皮细胞的损伤,促进VEGF的表达,刺激新生毛细血管增生,提高撕脱皮瓣的存活率。
[Abstract]:Objective: To study the protective effect of recombinant hirudin on the avulsion flap and its mechanism, and to explore the prospect of recombinant hirudin in the treatment of avulsion flap. Methods: 108 healthy SD rats were selected and divided into 3 groups randomly: 2 groups (group A: 2). The recombinant hirudin group, B group, low molecular weight heparin treatment group and 1 blank control group (group C: saline group), 36 rats in each group, with 40mg/kg weight, 1% pentobarbital sodium intraperitoneal injection, the middle back line as the criterion, the pedicle at the head side, and the design of 4cm x 6cm large rectangular free flap, the pedicle was protected and distal to the distal end. The stitches were attached to the weight of the fine weight after the stitches were fixed to the fine iron rod. The pulling force was given to 8kg. The time was 10 seconds to form a rip flap model, and the distal free margin was sutured after a little pruning. The pedicle of the flap was 12 hours, 24 hours and 48 hours after the operation, and the recombinant hirudin was injected subcutaneously from the pedicle of the pedicle, 2cm and 4cm three. 2mg/lml/ skin flap), low molecular weight heparin (2mg/lml/ flap), blank control group was given equal amount of saline injection (1m1/ flap) with the same method. After the operation, the hair growth, congestion, swelling, and the survival area of the skin flap were observed. The content of P- selectin in the distal tissue of 12h, 1D, 3D flaps after the operation was detected respectively, 3D, 5D, 7d skin flap in the distal tissue of the flap. The volume of inflammatory cells and the formation of microthrombosis in the distal sections of 12h, 1D, 3D, 5D and 7d were observed at high magnification.
Results: 1. gross observation: 12,24 hours after operation, 3 groups of skin flaps were cyanosis to different degrees, swelling, the blank control group was cyanosis and severe swelling compared with the two treatment group; the limit of Stasis Zone in the blank control group was clearer and the Stasis Zone of the treatment group was not clear. After the operation on day 5,7, the distal cyanosis, swelling gradually subsided, and the survival was good. The distal and peripheral skin of the skin flap were still swollen, dark black, the texture became hard, the surface hair was lost and no capillary reaction was found. The survival area percentage of the recombinant hirudin group and low molecular weight heparin group was (86.07 + 1.30)% and (81.46 + 1.06)%, respectively, fourteenth days after the operation, which were all higher than that in the blank control group (77.03 + 1.25)%. The survival rate of the flaps in the recombinant hirudin group was higher than that of the low molecular weight heparin group (P0.01). The difference was statistically significant (P0.05) 2. histological observation: after the operation, 12h: the blank control group showed massive hemorrhage area under the microscope, hyperemia, edema obviously, and a large number of neutrophils infiltration. The heparin group was seen under the heparin group the bleeding, congestion and edema were obvious under the heparin group. In the recombinant hirudin group, there was a lot of neutrophils infiltration, and the recombinant hirudin group showed punctate hemorrhage in the tissue under the microscope. There was congestion, edema, and a small amount of neutrophils infiltrating.1d. The blank control group was seen under the microscope, with massive hemorrhage area, congestive, edema, neutrophils aggregation, and early necrosis. Edema, neutrophils infiltration and so on were obvious. The recombinant hirudin group showed hyperemia, edema, and quantity of neutrophils scattered in the presence of.3d: in the blank control group, large hemorrhage in the tissue was seen under the microscope, the blood was obvious, and a large number of inflammatory granulation tissues were formed, and the neutrophils were found in the presence of neutrophils; the heparin group was under the microscope. There was blood, edema, and inflammatory granulation tissue in the tissue, and the neutrophils were scattered in the tissue, and the recombinant hirudin group was found to be scattered in the tissues and scattered in the tissues. The hemorrhage was rare, the inflammatory granulation tissue was formed, and a small amount of neutrophils scattered in.5d were found in the blank control group. In the heparin group, a small amount of congestion, edema, and inflammatory granulation tissue were more mature in the heparin group. The recombinant hirudin group showed a small amount of blood stasis and the inflammatory granulation tissue matured.7d. The microthrombus was formed in the blank control group, and the capillary was obliterated and the newborn capillaries were few. In the recombinant hirudin group, the recombinant hirudin group was found to be active in neovascularization and to detect the content of.3.P- selectin in granulation tissue (PG / M1): Twelfth hours, 1 days, 3, and P- selectin in the recombinant hirudin group and low molecular weight heparin group (129.740 + 12.302) and (151.584 + 12.409) (111.030 + 6.824) and 134.434 + 8.707), (101.674 + 4.429) and (118.308 + 7.535), the corresponding blank group was (196.034 + 18.442) (162.087 + 14.485), (132.473 + 8.142), Twelfth hours, 1 days, the difference between the recombinant hirudin group and the low molecular weight heparin group and the blank control group was statistically significant (P0.05).4.VEGF content detection: after 3,5,7 day after operation, the recombinant hirudin group and the low level The content of VEGF in the molecular heparin group was (212.507 + 15.096) and (158.733 + 15.311), (214.010 + 13.811) and (167.134 + 11.455), (218.093 + 13.464) and (177.484 + 8.183), and the corresponding blank group was (120.454 + 11.455). The difference between the recombinant hirudin group and the low molecular weight heparin group and the blank control group was poor. P0.05. Conclusion: local injection of recombinant hirudin can effectively inhibit the formation of P- selectin, reduce the accumulation of inflammatory cells, block the formation of microthrombus, improve local ischemia and hypoxia, weaken the damage of endothelial cells, promote the expression of VEGF, stimulate the proliferation of newborn capillaries, and increase the skin flap of the capillaries. The survival rate.
【学位授予单位】:泸州医学院
【学位级别】:硕士
【学位授予年份】:2012
【分类号】:R641;R-332

【相似文献】

相关期刊论文 前10条

1 赵振泽;新一代抗凝剂——重组水蛭素[J];国外医学.心血管疾病分册;1994年03期

2 田建伟,陈宏,刘朝中,江一清,朴龙松;重组水蛭素对兔髂总动脉球囊损伤后内膜增殖影响的实验研究[J];心脏杂志;2000年03期

3 陈桂良,陈钢;重组水蛭素的表达纯化及活性检测方法进展[J];药物生物技术;2004年01期

4 吴浩;重组水蛭素抗血栓作用研究进展[J];国外医学.药学分册;1995年04期

5 韩玉珉,鹿峪峰,王朝晖,吴淑荣,周建萍,李蜀平,关健达;重组水蛭素十二指肠给药后的抗凝血和抗血栓作用实验研究[J];中华血液学杂志;1999年09期

6 吕秋军,温利青,陈媛媛,李元敏,曲艳燕,郭绍明;重组水蛭素对Beagle犬凝血功能的影响[J];中国生化药物杂志;2003年01期

7 邵雷,周长林,范维,赵明龙;发酵液中重组水蛭素的分离纯化[J];中国药科大学学报;2003年03期

8 马雪瑛,林成仁,刘志去,王敏,葛争艳,石体仁,刘建勋,范开,王建,张益;重组水蛭素抗凝和抗血栓形成作用的实验研究[J];中国中医药科技;2004年01期

9 李超;张相年;石磊;;水蛭素及其临床应用[J];实用医学杂志;2007年21期

10 王朝晖,鹿峪峰,韩玉珉;重组水蛭素HV2的稳定性[J];中国生物化学与分子生物学报;1995年03期

相关会议论文 前10条

1 李运曼;孙宇;夏仁睿;崔莉;;重组水蛭素对大鼠白内障的防治作用[A];中国药理学会制药工业专业委员会第十一届学术会议论文摘要汇编[C];2004年

2 任洪灿;吕勇;李颖;杜洋;韩国柱;;N-~1Ile-~2Thr重组水蛭素在家兔体内的药物代谢动力学[A];中国药理学会制药工业专业委员会第十一届学术会议论文摘要汇编[C];2004年

3 周中和;曲方;;重组水蛭素对大鼠脑出血血肿周边组织TNF-α和ICAM-1的干预作用[A];第九次全国神经病学学术大会论文汇编[C];2006年

4 周中和;曲方;何祥;;重组水蛭素对大鼠脑出血细胞凋亡影响[A];第九次全国神经病学学术大会论文汇编[C];2006年

5 宋霞;刘新刚;莫炜;严小敏;戴林森;;新型重组双功能水蛭素溶液结构的研究[A];第十四届全国波谱学学术会议论文摘要集[C];2006年

6 黎明;张荣军;曹国宪;万卫星;张莲芬;金坚;;重组水蛭素促纤溶作用机理的研究[A];2006第六届中国药学会学术年会论文集[C];2006年

7 李雪芹;候蓓蓓;赵军;田明玉;修志龙;;重组水蛭素的聚乙二醇修饰[A];2008年中国药学会学术年会暨第八届中国药师周论文集[C];2008年

8 姜素云;张婷婷;矫建;徐永平;窦桂芳;;pNA法测定大鼠血浆中重组水蛭素[A];第九届全国药物和化学异物代谢学术会议论文集[C];2009年

9 王一楠;闫宇辉;韩国柱;梁骏;姜伟;陈晓芳;;应用生物测定法研究重组水蛭素自家兔尿、胆汁的排泄及其药代动力学[A];第八次全国药物与化学异物代谢学术会议论文摘要[C];2006年

10 郭应信;殷国前;李佳荃;肖汉;;天然、重组水蛭素对大鼠随意皮瓣淤血模型VEGF的影响[A];第七届中国医师协会美容与整形医师大会论文集[C];2010年

相关重要报纸文章 前7条

1 张肆文 林军强;重组水蛭素前景看好[N];医药经济报;2003年

2 张肄文 林军强;近1亿元[N];新华每日电讯;2003年

3 ;中药研究专辑[N];中国中医药报;2003年

4 蔡毓生;汕头保税区招商引资捷报频传[N];汕头日报;2007年

5 王忠良邋倪铁城 本报记者 丁秀玉;创新之旅[N];科技日报;2008年

6 徐亚静 鲁永勤;中药研发要坚持科学发展观[N];中国医药报;2009年

7 本报记者 孙晨 通讯员 吴延华;东阿阿胶“梅开二度”[N];中国高新技术产业导报;2002年

相关博士学位论文 前10条

1 郭应信;天然、重组水蛭素对大鼠随意皮瓣淤血模型的影响研究[D];广西医科大学;2011年

2 赵茜;VNP对大鼠碾压撕脱皮瓣iNOS及血浆NO的影响[D];第四军医大学;2010年

3 周碧蓉;动脉粥样硬化形成过程中纤维蛋白原与P-选择素的关系及作用研究[D];安徽医科大学;2012年

4 唐湘祁;NADPH氧化酶调节MMP-9和E选择素表达与缺血再灌注脑损伤的病理机制[D];中南大学;2011年

5 孙桂金;斑马鱼选择素及配体PSGL-1的研究[D];山东师范大学;2011年

6 落继先;PI3K在L-选择素和PSGL-1信号通路中的作用研究[D];东北师范大学;2010年

7 唐忠仁;养心颗粒对p53基因转染易损斑块家兔模型血清P-选择素、C反应蛋白含量及颈总动脉P-选择素mRNA表达的影响[D];黑龙江中医药大学;2011年

8 郭桅;阻断E-选择素缓解LPS诱导的急性肺损伤[D];第二军医大学;2012年

9 涂亚芳;树突状细胞在实验性糖尿病肾损害中作用及迁徒机制的研究[D];武汉大学;2011年

10 张庆富;经颅高压电烧伤对微血管内白细胞流变行为的影响及相关机制[D];河北医科大学;2010年

相关硕士学位论文 前10条

1 张祥运;重组水蛭素对大鼠撕脱皮瓣存活影响的实验研究[D];泸州医学院;2012年

2 许尔长;重组水蛭素诱导bFGF表达,促进静脉淤血皮瓣存活的实验研究[D];泸州医学院;2011年

3 江波;重组水蛭素对大鼠皮肤撕脱伤中CD11b、CD18及ICAM-1动态表达影响的研究[D];泸州医学院;2012年

4 王珂;基于自组装膜构建的重组水蛭素电容型免疫传感器的研究[D];四川大学;2004年

5 王黎;基于多囊脂质体技术的蛋白质类药物缓释传递系统的研究[D];重庆大学;2007年

6 李雪芹;水蛭素的分离纯化及其聚乙二醇修饰[D];大连理工大学;2008年

7 王一楠;应用生物测定法研究重组水蛭素自家兔尿、胆汁的排泄及其药代动力学[D];大连医科大学;2008年

8 侯蓓蓓;聚乙二醇单修饰重组水蛭素的研究[D];大连理工大学;2007年

9 肖汉;天然、重组水蛭素对大鼠随意皮瓣ET、TXB2的影响[D];广西医科大学;2010年

10 侯宇雁;P-选择素,胱抑素C在预测早期糖尿病肾病中的应用研究[D];山西医科大学;2010年



本文编号:1931150

资料下载
论文发表

本文链接:https://www.wllwen.com/xiyixuelunwen/1931150.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户0b473***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com